Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Tools of Reason: The Practice of Scientific Diagramming from Antiquity to the Present.

Priest G, De Toffoli S, Findlen P.

Endeavour. 2018 Jun - Sep;42(2-3):49-59. doi: 10.1016/j.endeavour.2018.07.001. Epub 2018 Aug 22. No abstract available.

PMID:
30143241
2.

Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer.

Toffoli S, Bar I, Abdel-Sater F, Delrée P, Hilbert P, Cavallin F, Moreau F, Van Criekinge W, Lacroix-Triki M, Campone M, Martin AL, Roché H, Machiels JP, Carrasco J, Canon JL.

Breast Cancer Res. 2014 Nov 22;16(6):466. doi: 10.1186/s13058-014-0466-y.

3.

Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data.

Boeva V, Popova T, Lienard M, Toffoli S, Kamal M, Le Tourneau C, Gentien D, Servant N, Gestraud P, Rio Frio T, Hupé P, Barillot E, Laes JF.

Bioinformatics. 2014 Dec 15;30(24):3443-50. doi: 10.1093/bioinformatics/btu436. Epub 2014 Jul 12.

4.

Proposal for a unified selection to medical residency programs.

Toffoli SF, Ferreira Filho OF, Andrade DF.

Rev Assoc Med Bras (1992). 2013 Nov-Dec;59(6):583-8. doi: 10.1016/j.ramb.2013.06.010. Epub 2013 Nov 9. English, Portuguese.

5.

Mesenchymal chondrosarcoma of the spleen: report of a case.

Rossetto A, Saccomano E, Zompicchiatti A, Avellini C, Toffoli S, Miolo G, Frustaci S, Uzzau A.

Tumori. 2011 Jul-Aug;97(4):e10-5. doi: 10.1700/950.10413.

PMID:
21989449
6.

NDRG1 and CRK-I/II are regulators of endothelial cell migration under Intermittent Hypoxia.

Toffoli S, Delaive E, Dieu M, Feron O, Raes M, Michiels C.

Angiogenesis. 2009;12(4):339-54. doi: 10.1007/s10456-009-9156-2. Epub 2009 Sep 17.

PMID:
19760510
7.

Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1.

Toffoli S, Roegiers A, Feron O, Van Steenbrugge M, Ninane N, Raes M, Michiels C.

Angiogenesis. 2009;12(1):47-67. doi: 10.1007/s10456-009-9131-y. Epub 2009 Jan 29.

PMID:
19184477
8.

Hypoxia regulates inflammatory gene expression in endothelial cells.

Flamant L, Toffoli S, Raes M, Michiels C.

Exp Cell Res. 2009 Mar 10;315(5):733-47. doi: 10.1016/j.yexcr.2008.11.020. Epub 2008 Dec 7.

PMID:
19101540
9.

Pathological changes and myocardial remodelling related to the mode of shunting following surgical palliation for hypoplastic left heart syndrome.

Padalino MA, Castellani C, Toffoli S, Della Barbera M, Milanesi O, Thiene G, Stellin G, Angelini A.

Cardiol Young. 2008 Aug;18(4):415-22. doi: 10.1017/S1047951108002461. Epub 2008 Jun 30.

PMID:
18588727
10.

Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours.

Toffoli S, Michiels C.

FEBS J. 2008 Jun;275(12):2991-3002. doi: 10.1111/j.1742-4658.2008.06454.x. Epub 2008 Apr 25. Review.

11.

Dual effect of echinomycin on hypoxia-inducible factor-1 activity under normoxic and hypoxic conditions.

Vlaminck B, Toffoli S, Ghislain B, Demazy C, Raes M, Michiels C.

FEBS J. 2007 Nov;274(21):5533-42. Epub 2007 Oct 4.

12.

Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKA-dependent regulation of HIF-1alpha.

Toffoli S, Feron O, Raes M, Michiels C.

Biochim Biophys Acta. 2007 Oct;1773(10):1558-71. Epub 2007 Jun 16.

13.

Hypoxia and CoCl2 protect HepG2 cells against serum deprivation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1.

Piret JP, Lecocq C, Toffoli S, Ninane N, Raes M, Michiels C.

Exp Cell Res. 2004 May 1;295(2):340-9.

PMID:
15093734
14.

Exogenous heparin reduces soluble plasma thrombomodulin levels.

Cella G, Rampin E, Sbarai A, Meneghin C, Toffoli S, Girolami A.

Blood Coagul Fibrinolysis. 1997 Sep;8(6):365-6. No abstract available.

PMID:
9351527
15.

Splenomegaly as the first manifestation of thyroid cancer metastases.

Paolini R, Toffoli S, Poletti A, Casara D, Moschino P, Fabris F, Girolami A.

Tumori. 1997 Jul-Aug;83(4):779-82.

PMID:
9349322
16.

The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis.

Cella G, Conard J, Manai S, Luzzatto G, Paolini R, Toffoli S, Boeri G, Vianello A, Girolami A, Samama MM, Strauss WE.

Hematology. 1997;2(3):235-41. doi: 10.1080/10245332.1997.11746342.

PMID:
27406868
17.

Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases.

Fritzler MJ, von Muhlen CA, Toffoli SM, Staub HL, Laxer RM.

J Rheumatol. 1995 Mar;22(3):521-4.

PMID:
7783073
18.

Tissue factor pathway inhibitor activity in factor VII deficiency.

Cella G, Vianello A, Boeri G, Toffoli S, Paolini R, Rampin E, Girolami A.

J Med. 1995;26(3-4):189-91. No abstract available.

PMID:
8558100

Supplemental Content

Loading ...
Support Center